VIA
CC icon

Vident Investment Advisory’s Chemours CC Stock Holding History

Vident Investment Advisory’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-7,017
Closed -$259K – 176
2023
Q2 		$259K Buy
+7,017
New +$214K 0.01% 952
2017
Q3 		– Sell
-6,529
Closed -$248K – 739
2017
Q2 		$248K Sell
6,529
-2,429
-27% -$95.8K 0.02% 419
2017
Q1 		$345K Buy
+8,958
New +$270K 0.03% 350

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vident Investment Advisory's CC Position: Q3 2023 in Review

Vident Investment Advisory sold out of Chemours (CC) in Q3 2023, closing a stake of 7,017 shares — an estimated $259K sold.

Vident Investment Advisory first reported a position in CC in Q1 2017 and held it in 3 quarters. The position peaked at $345K in Q1 2017. 455 funds tracked by Wall St. Rank hold CC as of Q3 2023.

  • Vident Investment Advisory reported no remaining Chemours position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 7,017 Chemours shares in Q3 2023, an estimated $259K.
  • Vident Investment Advisory first reported a position in Chemours in Q1 2017 and held it in 3 quarters.
  • Vident Investment Advisory's Chemours position peaked at $345K in Q1 2017.
  • 455 funds tracked by Wall St. Rank held Chemours as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.